BioCentriq

About:

BioCentriq is a cell and gene therapy development and manufacturing center.

Website: https://biocentriq.com

Twitter/X: BioCentriq

Top Investors: National Institute for Innovation in Manufacturing Biopharmaceuticals

Description:

BioCentriq is the cell and gene therapy development and manufacturing center. Leveraging state-of-the-art facilities, cutting-edge technologies, and a team of seasoned professionals, the company has a demonstrated history of effectively transferring, developing and manufacturing GMP drug products for clinical trial use. BioCentriq is committed to driving innovation in cell therapy and assisting its partners in delivering transformative treatments to patients globally.

Total Funding Amount:

$29.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newark, New Jersey, United States

Founded Date:

2019-01-01

Founders:

Haro Hartounian

Number of Employees:

101-250

Last Funding Date:

2024-01-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai